Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
基本信息
- 批准号:10084274
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-10 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAnthelminticsAntigensAntiparasitic AgentsBiological AssayBlood donorBlood specimenBrainBrain DiseasesCenters for Disease Control and Prevention (U.S.)ChemistryClinicalCollaborationsComplexComputer softwareCystDataDetectionDevelopmentDevicesDiagnosisDiagnosticDiseaseElectroencephalogramElectroencephalographyEngineeringEnsureEnzymesEpilepsyEtiologyEuropeFamily suidaeFrequenciesGoalsGoldHumanHygieneImageImmigrationImmunoassayIncomeIndividualInfectionInfrastructureLabelLaboratoriesLateralLocationMagnetic Resonance ImagingMeasurementMedicalMembraneMethodsNeurocysticercosisParasitic DiseasesParasitic infectionPatientsPerformancePhasePreparationPriceProceduresPublishingReaderReagentRecombinantsReproducibilityResistanceRunningSamplingSeizuresSensitivity and SpecificitySerology testSerumSpecificityStructural defectSynthetic AntigensTaenia soliumTemperatureTest ResultTestingTissuesTrainingTravelVariantWhole BloodWireless TechnologyWorld Health Organizationantibody detectionbaseclinical Diagnosiscostdesigndetection sensitivityeffective therapyfollow-upimaging studyinfection ratelateral flow assaymedical specialtiesnervous system disordernervous system infectionnovelperformance testspoint of carepoint of care testingprototyperelating to nervous systemresearch clinical testingscale upstatisticstoolvalidation studies
项目摘要
Project Summary
Epilepsy, a disorder of the brain manifested by seizures, is the fourth most prevalent neurological disease,
affecting over 50 million people worldwide, or about 1 out of 150 individuals on average. The frequency of
epilepsy is distributed unevenly, however, with the vast majority of cases occurring in less developed regions
of the world. The explanation for this distribution is most likely that one third of all epilepsy cases are due to
Neurocysticercosis, known to be the most common parasitic infection of the nervous system.
Neurocysticercosis is caused by the presence of larval cysts of Taenia solium, the pork tapeworm, in the brain,
which can cause seizures and illness ranging from mild to fatal depending on their location, number and
viability. In contrast to idiopathic epilepsy, a complex disease which can be difficult to treat and resistant to
cure, Neurocysticercosis can be treated and in many cases cured with inexpensive and available anti-
helminthic drugs. Distinguishing whether the cause of seizures is idiopathic epilepsy or Neurocysticercosis is
thus a critical part of the diagnostic workup and essential to determine the appropriate course of treatment for
patients. The established procedures for diagnosing epilepsy comprise electroencephalography and imaging
via MRI, but these sophisiticated tools are of limited availability in the less developed world where
Neurocysticercosis is most frequent. On the other hand, Neurocysticercosis can be diagnosed with a
serological test that detects antibodies to T. solium cysts. The gold standard serological test, the Enzyme
Immunotransfer Blot (EITB) developed at CDC, is a laboratory-based test, however, that is not widely available
and requires significant training to carry out. Thus there is a critical need for a rapid, commercially available
point-of-care test for Neurocysticercosis that can be used to test patients with seizures, in order to identify
those with the parasitic infection so that they can be treated effectively. Development of such a test has been
identified as an urgent priority by the World Health Organization.
In the Phase I project, we will utilize recombinant and synthetic T. solium antigens corresponding to those used
in the EITB to develop a point-of-care serological test for Neurocysticercosis that will meet the criteria in the
World Health Organization’s Target Product Profile. These antigens have shown high sensitivity and specificity
in prior studies, and will be combined to further increase sensitivity for detection of single viable cysts, the most
challenging case. The point-of-care Neurocysticercosis test will be evaluated for sensitivity on a well-
characterized panel of sera from Neurocysticercosis patients confirmed by EITB or clinical diagnosis, and for
specificity on healthy controls and other disease state sera. Test results will be read using a field-friendly,
ultraportable, low-cost reader that will provide objective interpretation and enable wireless upload of data to
local devices or remote servers. Phase II will support complete development to commercial stage, clinical
evaluation and preparation for CE mark and FDA submission of the Neurocysticercosis point-of-care test.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew E. Levin其他文献
Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
对莱姆病序贯酶免疫分析测试算法的评估表明缺乏测试独立性,但诊断特异性较高。
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:2.9
- 作者:
G. Wormser;Claudia R. Molins;Andrew E. Levin;Susan C. Lipsett;L. Nigrovic;M. Schriefer;J. Branda - 通讯作者:
J. Branda
The Babesia observational antibody (BAOBAB) study: A cross-sectional evaluation of Babesia in two communities in Kilosa district, Tanzania
巴贝虫观察性抗体 (BAOBAB) 研究:坦桑尼亚基洛萨区两个社区巴贝虫横断面评估
- DOI:
10.1371/journal.pntd.0007632 - 发表时间:
2019 - 期刊:
- 影响因子:3.8
- 作者:
E. Bloch;Z. Mrango;M. Kasubi;Jerusha Weaver;Aleksandra Mihailovic;B. Munoz;A. Weimer;Andrew E. Levin;L. Tonnetti;J. Linnen;V. Brès;D. Norris;G. Carpi;S. West - 通讯作者:
S. West
Frequency and magnitude of seroreactivity to <em>Babesia microti</em> in 245 patients diagnosed by PCR in New York State
- DOI:
10.1016/j.diagmicrobio.2020.115008 - 发表时间:
2020-05-01 - 期刊:
- 影响因子:
- 作者:
Susan Madison-Antenucci;Gary P. Wormser;Andrew E. Levin;Susan J. Wong - 通讯作者:
Susan J. Wong
Andrew E. Levin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew E. Levin', 18)}}的其他基金
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
- 批准号:
10603665 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Development of an ELISA for serosurveillance of human hookworm
开发用于人类钩虫血清监测的 ELISA
- 批准号:
10697222 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
- 批准号:
9909230 - 财政年份:2020
- 资助金额:
$ 30万 - 项目类别:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
用于诊断癫痫患者神经囊尾蚴病的快速护理点检测
- 批准号:
10699435 - 财政年份:2020
- 资助金额:
$ 30万 - 项目类别:
Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
混合 ELISA:针对莱姆病的简单而特异的一层检测
- 批准号:
9886194 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Biomarker-Based Test of Cure for Chagas Disease
基于生物标记的恰加斯病治愈测试
- 批准号:
10761244 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
混合 ELISA:针对莱姆病的简单而特异的一层检测
- 批准号:
10758919 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
- 批准号:
9757680 - 财政年份:2018
- 资助金额:
$ 30万 - 项目类别:
Serologic assays for detection of Zika virus antibodies for clinical diagnosis and blood donor counseling
用于检测寨卡病毒抗体的血清学检测,用于临床诊断和献血者咨询
- 批准号:
10221519 - 财政年份:2017
- 资助金额:
$ 30万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Scientific Research (C)